Palliative Medicine,
Год журнала:
2025,
Номер
unknown
Опубликована: Апрель 1, 2025
Background:
For
people
in
receipt
of
palliative
care,
where
polypharmacy
is
common
and
medication
burden
high,
there
remains
limited
knowledge
around
the
decision-making
processes
that
underpin
deprescribing;
for
example,
recent
deprescribing
studies
have
focused
on
wider
issues
identifying
care
contexts.
However,
little
known
about
specific
challenges
of,
preferences
towards,
to
support
care.
Aim:
To
explore
approaches,
based
experiences
their
family
member(s).
Design:
An
explorative
qualitative
study
involving
in-person
semi-structured
interviews,
analysed
using
reflexive
thematic
analysis.
Setting/participants:
Twenty-five
interviews
were
conducted
with
(
n
=
25),
12
these
undertaken
as
dyads,
both
patient
a
member
together.
Interviews
across
range
settings,
spanning:
hospice
outpatient
day
units
11),
inpatient
wards
4),
home
1)
patients’
own
homes
9),
involved
diverse
diagnoses
(including:
cancer
52%,
heart
failure
20%,
motor
neurone
disease
12%,
pulmonary
fibrosis
4%
chronic
obstructive
4%).
Results:
Two
overarching
themes
developed
–
first
reflected
need
address
understanding
by
‘laying
foundations
decision-making’.
The
second
theme,
‘having
voice
decision-making’,
desires
(pro)-actively
involve
patients
member(s)
within
processes.
Conclusion:
There
take
balanced,
person-centred
shared
approach
receiving
Co-design
strategies
offer
one
further
this.
JAMA Internal Medicine,
Год журнала:
2018,
Номер
178(12), С. 1673 - 1673
Опубликована: Окт. 16, 2018
Use
of
harmful
and/or
unnecessary
medications
in
older
adults
is
prevalent.
This
can
lead
to
avoidable
harms
such
as
adverse
drug
reactions,
falls,
hospitalization,
and
mortality.
Primary
care
physicians
report
that
patient
resistance
discontinuing
medication
use
a
significant
barrier
deprescribing.To
describe
the
attitudes
toward
deprescribing
determine
whether
individual
characteristics
are
associated
with
these
attitudes.For
this
population-based
survey
study
US
Medicare
beneficiaries
65
years
older,
data
were
obtained
from
Medication
Attitudes
module
fielded
through
in-person
interviews
round
6
National
Health
Aging
Trends
Study
(weighted
response
rate
was
88.5%).
The
questions
drawn
Patients'
Towards
Deprescribing
questionnaire
its
revised
version.
random
one-third
(n
=
2124)
participants
94.8%).Responses
2
statements
("If
my
doctor
said
it
possible,
I
would
be
willing
stop
one
or
more
regular
medicines"
"I
like
reduce
number
medicines
am
taking")
main
outcomes
interest.Of
1981
included
study,
1149
(55.2%,
weighted)
women,
majority
715
[54.6%,
weighted])
74
old.
A
total
1752
(92.0%,
reported
being
taking
1
their
if
physician
1241
(66.6%,
wanted
they
taking.
Older
had
greater
odds
than
those
fewer
(adjusted
ratio,
2.90;
95%
CI,
1.74-4.82)
wanting
2.31;
1.71-3.13).Physicians
considering
part
comprehensive,
patient-centered
should
reassured
Americans
open
having
deprescribed
says
two-thirds
want
JAMA Internal Medicine,
Год журнала:
2023,
Номер
183(3), С. 223 - 223
Опубликована: Фев. 6, 2023
Deprescribing
is
a
promising
approach
to
addressing
the
burden
of
polypharmacy.
Few
studies
have
initiated
comprehensive
deprescribing
in
hospital
setting
among
older
patients
requiring
ongoing
care
postacute
(PAC)
facility.
The Journals of Gerontology Series B,
Год журнала:
2017,
Номер
73(7), С. e98 - e107
Опубликована: Окт. 16, 2017
Polypharmacy
in
the
older
population
is
increasing-and
can
be
harmful.
It
safe
to
reduce
or
carefully
cease
medicines
(deprescribing)
but
a
collaborative
approach
between
patient
and
doctor
required.
This
study
explores
decision-making
about
polypharmacy
with
adults
their
companions.
Semi-structured
interviews
were
conducted
30
people
(aged
75+
years,
taking
multiple
medicines)
15
Framework
analysis
was
used
identify
qualitative
themes.
Participants
varied
considerably
attitudes
towards
medicines,
preferences
for
involvement
decision-making,
openness
deprescribing.
Three
types
identified.
Type
1
held
positive
preferred
leave
decisions
doctor.
2
voiced
ambivalent
proactive
role,
open
3
frail,
perceived
they
lacked
knowledge
deferred
most
companion.
provides
novel
typology
describe
differences
who
are
happy
take
those
To
enable
shared
prescribers
need
adapt
communication
based
on
patients'
decisions.
Journal of the American Geriatrics Society,
Год журнала:
2019,
Номер
67(6), С. 1204 - 1210
Опубликована: Фев. 13, 2019
BACKGROUND/OBJECTIVES
Use
of
harmful
and/or
unnecessary
medications
in
older
adults
is
common.
Understanding
adult
and
caregiver
attitudes
toward
deprescribing
will
contribute
to
medication
optimization
practice.
The
aims
this
study
were
capture
the
beliefs
caregivers
determine
what
participant
characteristics
(if
any)
predicted
reported
willingness
have
a
deprescribed.
DESIGN
Self‐completed
questionnaire.
SETTING
Australia.
PARTICIPANTS
Older
(n
=
386),
65
years
or
older,
taking
one
more
regular
prescription
205)
who
could
self‐complete
written
questionnaire
English.
MEASUREMENTS
versions
validated
revised
Patients’
Attitudes
Towards
Deprescribing
(rPATD)
completed.
rPATD
includes
two
global
questions
four
factors:
perceived
burden
medications,
belief
appropriateness
concerns
about
stopping,
involvement
management.
Participant
characteristics,
self‐rated
health,
trust
physician,
health
autonomy
also
collected.
RESULTS
participants
had
median
age
74
(interquartile
range
[IQR]
70‐81
y),
aged
67
(IQR
59‐76)
caring
for
person
81
75‐86.25
y).
Most
both
(88%)
(84%)
agreed
strongly
that
they
would
be
willing
stop
their
care
recipient's
if
doctor
said
it
was
possible.
In
binary
logistic
regression
model,
low
concern
stopping
factor
score
strongest
predictor
deprescribed
(odds
ratio
[OR]
0.12;
95%
confidence
interval
[CI]
0.04‐0.34).
Excellent/good
rating
physical
(OR
3.71;
CI
1.13‐12.23).
CONCLUSIONS
are
deprescribed,
although
different
predictors
(characteristics/attitudes)
identified
these
groups.
Expert Review of Clinical Pharmacology,
Год журнала:
2020,
Номер
13(3), С. 233 - 245
Опубликована: Фев. 14, 2020
Introduction:
There
is
increasing
recognition
of
the
need
for
deprescribing
inappropriate
medications
in
older
adults.
However,
efforts
to
encourage
implementation
clinical
practice
have
resulted
mixed
results
across
settings
and
countries.Area
covered:
Searches
were
conducted
PubMed,
Embase,
Google
Scholar
June
2019.
Reference
lists,
citation
checking,
personal
reference
libraries
also
utilized.
Studies
capturing
main
challenges
of,
opportunities
for,
implementing
into
selected
health-care
internationally,
international
deprescribing-orientated
policies
included
summarized
this
narrative
review.Expert
opinion:
Deprescribing
intervention
studies
are
inherently
heterogeneous
because
complexity
interventions
employed
often
do
not
reflect
real-world.
Further
research
investigating
enhanced
required.
Process
evaluations
needed
determine
contextual
factors
that
important
translation
may
be
individually
tailored
target
unique
barriers
different
settings.
Introduction
national
beneficial,
but
evaluated
if
there
any
unintended
consequences.
Journal of Clinical Pharmacy and Therapeutics,
Год журнала:
2018,
Номер
43(4), С. 550 - 555
Опубликована: Апрель 22, 2018
What
is
known
and
objective
Deprescribing
the
process
of
discontinuing
or
reducing
dosage
medications
that
are
no
longer
appropriate
aligned
with
goals
care,
which
paramount
in
elderly
patients
multiple
comorbidities
polypharmacy.
The
this
study
was
to
assess
perceptions
primary
care
physicians
on
deprescribing
for
potential
barriers
experience
Local
Health
Authority
(LHA)
Parma,
Emilia-Romagna,
Italy.
Methods
One
hundred
sixty
(57%
total
number
Parma)
attended
an
educational
session
related
were
asked
anonymously
complete
a
paper
survey.
Participants
their
level
agreement
nine
questions
about
perception
factors
affecting
using
seven-point
Likert-type
scale.
A
correlation
coefficient
calculated
association
between
physicians'
confidence
attitudes
associated
deprescribing.
Results
discussion
Many
(72%)
reported
general
ability
deprescribe.
Most
respondents
(78%)
they
comfortable
preventive
medications,
yet
only
half
(53%)
guideline-recommended
therapies.
Lack
evidence
medicines
concern
withdrawal
side
effects
impede
by
more
than
one-third
physicians.
When
initially
prescribed
another
physician,
40%
hesitance
them.
About
(45%)
did
not
feel
when
patients/caregivers
believed
continuation
medication
needed.
time
difficulty
engaging
cited
as
one
four
There
strong
new
conclusion
results
show
believe
generally
deprescribing,
although
there
still
several
hamper
engage
process.
An
improved
understanding
views
may
help
guide
further
research,
policies
remain
healthy
while
streamlining
regimen.
Therapeutic Advances in Drug Safety,
Год журнала:
2017,
Номер
9(1), С. 25 - 43
Опубликована: Окт. 27, 2017
Background:
The
aim
of
this
study
was
to
evaluate
efficacy
and
safety
poly-de-prescribing
(PDP)
based
on
the
Garfinkel
method
in
older
people
with
polypharmacy.
Methods:
A
longitudinal,
prospective,
nonrandomized
Israel
carried
out
between
2009
2016.
Comprehensive
geriatric
assessments
were
performed
at
home
age
⩾66
years
consuming
⩾6
prescription
drugs.
Exclusion
criteria
life
expectancy
<6
months
a
seeming
unwillingness
cooperate
(poor
compliance).
PDP
⩾3
drugs
recommended.
Follow
up
years.
Between
April
2015
2016
Likert
scale
questionnaires
filled
by
all
participants/families
overall
satisfaction
clinical
outcomes.
outcome
measures
change
functional,
mental
cognitive
status,
sleep
quality,
appetite,
continence;
major
complication,
hospitalizations,
mortality,
family
doctor’s
cooperation.
Results:
Poly-de-prescribing
eventually
achieved
122
participants
(PDP
group);
⩽2
stopped
55
‘nonresponders’
(NR
group).
average
83.4
±
5.3
group,
80.8
6.3
NR
group
(
p
=
0.0045).
43.6
14
39.5
16.6
(NR)
0.09).
prevalence
most
diseases/symptoms
comparable
except
for
higher
dementia,
incontinence
functional
decline
group.
main
barrier
de-prescribing
adopt
recommendations
<
0.0001).
baseline
median
number
medications
taken
both
groups
10
(IQR
8
12)
0.55).
On
last
follow
up,
drug
count
11
4
2
5)
=0.0001).
showed
significantly
less
deterioration
(sometimes
improvement)
general
satisfaction,
sphincter
control,
complications
reduced
0.002
all).
rate
hospitalizations
mortality
comparable.
Health
improvement
occurred
within
3
after
83%,
persisted
⩾2
68%.
Conclusions:
This
self-selected
sample
longitudinal
research
strongly
suggests
that
negative,
usually
invisible
effects
polypharmacy
are
reversible.
is
well
tolerated
associated
improved
outcomes,
comparison
outcomes
who
adhere
guidelines
take
conventionally.
Future
double-blind
studies
will
probably
prove
beneficial
economic
as
well.
Health Science Reports,
Год журнала:
2018,
Номер
1(7)
Опубликована: Май 10, 2018
Abstract
Aims
This
review
investigates
the
factors
that
influence
deprescribing
of
medications
in
primary
care
from
perspective
general
practitioners
(GPs)
and
community‐living
older
adults.
Methods
A
mixed
studies
structure
was
adopted
searching
Scopus,
CINAHL,
PsychINFO,
ProQuest,
PubMed
January
2000
to
December
2017.
manual
search
reference
lists
also
conducted.
Studies
were
included
if
they
original
research
available
English
explored
rather
than
a
specific
class
medications.
The
Mixed
Assessment
Tool
used
assess
quality
studies,
content
analysis
generated
common
categories
across
studies.
Results
Thirty‐eight
articles
included,
7
key
identified.
found
are
similar
within
health
systems
mostly
act
as
barriers.
These
remained
unchanged
period.
structural
organisation
remains
poorly
suited
facilitate
deprescribing.
Individual
knowledge
gaps
both
GPs
adults
practices
attitudes
towards
deprescribing,
significant
communication
occur
between
specialists
As
result,
decision
making
is
characterised
by
uncertainty,
often
considered
only
when
medication
problems
have
already
arisen.
Trust
plays
complex
role,
acting
barrier
facilitator
Conclusions
Deprescribing
influenced
many
factors.
Despite
recent
interest,
little
change
has
occurred.
Multilevel
strategies
aimed
at
reforming
aspects
system
managing
uncertainty
practice
individual
level,
notably
reducing
limitations
closing
communications
gaps,
may
achieve
change.